Nexalis Therapeutics Limited (ASX:NX1)
0.0230
-0.0020 (-8.00%)
At close: Apr 29, 2026
Nexalis Therapeutics Market Cap
Nexalis Therapeutics has a market cap or net worth of 5.82 million as of April 29, 2026. Its market cap has decreased by -25.20% in one year.
Market Cap
5.82M
Enterprise Value
6.12M
Revenue
986.43K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since January 11, 2017, Nexalis Therapeutics's market cap has decreased from 29.98M to 5.82M, a decrease of -80.58%. That is a compound annual growth rate of -16.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zelira Therapeutics | 5.95M |
| Acrux | 4.52M |
| Chimeric Therapeutics | 6.63M |
| Vectus Biosystems | 7.21M |
| Invex Therapeutics | 7.52M |
| Biotron | 8.11M |
| Anatara Lifesciences | 3.16M |
| Tissue Repair | 9.37M |